Charles Theillet

5PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 10, 2025
Prognostic Value of Trop-2 Expression in Nonmetastatic Triple-Negative Breast Cancer and Correlation With Emerging Biomarkers.

William Jacot, Marie-Christine Chateau, Simon Thezenas

|Jan 29, 2025
Replication-Poison Treatment in BRCA1-Deficient Breast Cancer Causes MRE11 Over-Resection That Induces Single-Stranded DNA Accumulation and Mitotic Catastrophe.

Imene Tabet, Esin Orhan, Ermes Candiello

|Mar 18, 2022
In high-grade ovarian carcinoma, platinum-sensitive tumor recurrence and acquired-resistance derive from quiescent residual cancer cells that overexpress CRYAB, CEACAM6, and SOX2.

Stanislas du Manoir, Hélène Delpech, Béatrice Orsetti

|Sep 22, 2020
A predictable conserved DNA base composition signature defines human core DNA replication origins.

Ildem Akerman, Bahar Kasaai, Alina Bazarova

|May 17, 2019
Distinct oncogenes drive different genome and epigenome alterations in human mammary epithelial cells.

Claire Fonti, Anne Saumet, Amanda Abi-Khalil

Pageof 1

Frequent Collaborators

4 joint publications

William Jacot

2 joint publications

Claude Sardet

1 joint publications

Ildem Akerman

1 joint publications

Pau Biak Sang